Skip to main content
. 2021 Nov 16;5(8):e12618. doi: 10.1002/rth2.12618

FIGURE 2.

FIGURE 2

Overall event‐free survival analysis of patients of 2‐year period (1 year before aspirin sensitivity analysis to 1 year after analysis). When comparing event‐free survival between aspirin‐sensitive and aspirin‐nonsensitive patients, the hazard of death was 3.68 (3.68; 95% confidence interval, 1.66‐8.17; P = .001)